AI cuts Changzhou power connection planning from days to minutes

AI cuts Changzhou power connection planning from days to minutes

An AI-powered digital upgrade to power supply services in Changzhou, China, has reduced custom power solution preparation time from 3–5 working days to just 3–5 minutes.
IBM and OpenAI deploy frontier AI to counter machine-speed cyber threats

IBM and OpenAI deploy frontier AI to counter machine-speed cyber threats

IBM has joined the OpenAI Daybreak Cyber Partner Program to bring advanced frontier AI capabilities into security operations, helping enterprises defend against machine-speed threats.
CARsgen wins world-first CAR T-cell approval for solid tumours

CARsgen wins world-first CAR T-cell approval for solid tumours

CARsgen Therapeutics announced that China's NMPA has approved Satri-cel, marking the world's first CAR T-cell therapy product approved for solid tumours.
Novogene says US DoD erroneously listed it on 1260H list

Novogene says US DoD erroneously listed it on 1260H list

Novogene announced that the U.S. Department of Defense erroneously designated it on the Section 1260H list, and the company is seeking correction.
GoVeda secures seed funding for AI IP platform

GoVeda secures seed funding for AI IP platform

GoVeda secured seed funding to accelerate development of its AI-native intellectual property platform that turns IP into a revenue engine for businesses.
Boutiqaat reportedly plans IPO for early 2027

Boutiqaat reportedly plans IPO for early 2027

Boutiqaat is positioned for expansion following reports of a potential IPO as early as the first quarter of 2027, according to Bloomberg.
BlueNexus unveils AquaX Hub for AI water operations

BlueNexus unveils AquaX Hub for AI water operations

BlueNexus Technologies debuted AquaX Hub at Singapore International Water Week 2026, a plug-and-play edge device bringing AI autonomous operations to legacy water assets.
Innovent doses first patient in multiple myeloma trial

Innovent doses first patient in multiple myeloma trial

Innovent Biologics dosed the first patient in a Phase 3 trial of IBI3003, a trispecific antibody for multiple myeloma.
LOTTE Biologics completes Songdo Plant 1 construction

LOTTE Biologics completes Songdo Plant 1 construction

LOTTE Biologics completed construction and obtained use approval for Plant 1 at its Songdo Bio Campus in Incheon, South Korea.
VivaTech 2026 surpasses 200,000 visitors

VivaTech 2026 surpasses 200,000 visitors

VivaTech 2026 celebrated its 10th anniversary with a record edition that surpassed 200,000 visitors, featuring French President Macron and Indian PM Modi.
Korea Deep Learning wins top AI benchmark ranking

Korea Deep Learning wins top AI benchmark ranking

Korea Deep Learning's Document AI secured the #1 overall ranking on ParseBench, a global document parsing benchmark, beating major tech firms.
Antengene licenses ATG-106 to K2 Therapeutics

Antengene licenses ATG-106 to K2 Therapeutics

Antengene entered an exclusive license agreement with K2 Therapeutics for ATG-106 and granted an option for an undisclosed bispecific TCE asset.
LG Display OLED gets world's first Perfect Color certification

LG Display OLED gets world's first Perfect Color certification

LG Display's entire large-sized OLED panel lineup became the world's first to receive "Perfect Color/Brightness" certification from an independent testing authority.
|< < 1 2 3 4 > >|